SCHEMBL4685358

SCHEMBL4685358

COC(=O)C(=Cc1ccc(C#N)cc1OC[C@H](CCC(=O)OCc1ccccc1)NC(=O)c1cccc(I)c1)NC(C)=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PIN1 Q13526 1/20 0.32
MRGPRX4 Q96LA9 3/20 0.32
HDAC1 Q13547 1/20 0.31
SMPD1 P17405 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
GPR132 Q9UNW8 1/20 0.30
MMP2 P08253 1/20 0.30
F10 P00742 1/20 0.30
PRSS1 P07477 1/20 0.30
FNTA P49354 1/20 0.30
FNTB P49356 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4685355 1.00 CYP3A4 (0.32) CYP3A4CYP2D6CYP2C9CYP2C19PIN1
SCHEMBL4685353 1.00 CYP3A4 (0.32) CYP3A4CYP2D6CYP2C9CYP2C19PIN1
SCHEMBL4686997 0.92 KAT6A (0.36) CYP3A4CYP2D6CYP2C9CYP2C19PIN1
SCHEMBL4685038 0.92 KAT6A (0.36) CYP3A4CYP2D6CYP2C9CYP2C19PIN1
SCHEMBL4687000 0.92 KAT6A (0.36) CYP3A4CYP2D6CYP2C9CYP2C19PIN1
Trifluoroacetic Acid SCHEMBL4681491 0.86 SLC2A1 (0.34) CYP3A4CYP2D6CYP2C9CYP2C19HDAC1
Trifluoroacetic Acid SCHEMBL4684972 0.86 CTSL (0.35) HDAC1GPR132FNTAFNTB
SCHEMBL4684280 0.85 CTSS (0.36)
SCHEMBL4684286 0.85 CTSS (0.36)
SCHEMBL4684284 0.85 CTSS (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1236712-B1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE AJINOMOTO KK (JP) 2008-08-06 EP disclosed
US-6710056-B2 PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVE AN EXCELLENT ANTAGONISTIC EFFECT AGAINST ACTIVATED BLOOD COAGULATION FACTOR VII. AJINOMOTO CO., INC. (JP) 2004-03-23 US disclosed
US-20030109547-A1 Amidinophenylpyruvic acid derivatives AJINOMOTO CO. INC (JP) 2003-06-12 US disclosed
EP-1236712-A1 AMIDINOPHENYLPYRUVIC ACID DERIVATIVE Ajinomoto Co., Inc. (JP) 2002-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109547-A1 Amidinophenylpyruvic acid derivatives HABP2, F2, F7 CYP3A4 85/4885CYP2D6 105/4885CYP2C9 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.